Skip to content

Clinical trials

Phase 1/2 Neoplasm Metastasis trials in Germany

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Neoplasm Metastasis Phase: Phase 1/2 Country / region: Germany Clear all

27 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20081
20092
20101
20111
20121
20132
20162
20203
20211
20225
20232
20242
20251
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting9
Completed8
Active, not recruiting5
Terminated2
Unknown status2
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals3
Eli Lilly and Company2
Merck Sharp & Dohme LLC2
Nuvalent Inc.2
Anaveon AG1
AstraZeneca1
BioInvent International AB1
CureVac1
EMD Serono1
Edwards Lifesciences1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Neoplasm Metastasis27
Neoplasms8
Carcinoma, Non-Small-Cell Lung5
Colorectal Neoplasms5
Melanoma5
Lung Neoplasms4
Pancreatic Neoplasms4
Recurrence4
Breast Neoplasms3
Endometrial Neoplasms3

Trials

Showing 1 to 25 of 27. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.